Enovix Corporation vs Genworth Financial Inc Common Stock — how do they compare? Enovix Corporation trades at $2.38 (market cap $550.82M), while Genworth Financial Inc Common Stock trades at $8.82 (market cap $3.36B). The key difference: Genworth Financial Inc Common Stock is far larger — about 6.1× Enovix Corporation's market cap, and Genworth Financial Inc Common Stock is trading nearer its 52-week high, Enovix Corporation nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Enovix Corporation for 11 Days and Genworth Financial Inc Common Stock for 0 Days on average.
| ENVX | GNW | |
|---|---|---|
Market Cap | $550.82M | $3.36B |
Volume | 5,977,872 | 3,333,156 |
Sector | Industrials | Financials |
52-Week High | $13.19 | $10.60 |
52-Week Low | $2.44 | $7.94 |
Typical Hold Time | 11 Days | 0 Days |
Enterprise Value | $612.51M | $2.87B |
Signals from Pluang's Aura AI — not financial advice
ENVX trades at $2.51, down 3.09% on the day, reflecting bearish technical signals and negative profitability. The company reported a net loss of -$156.74M in 2025, with revenue of $31.82M, while recent quarterly EPS has consistently beaten expectations. Key developments include a CEO transition in August 2026 and expansion of drone battery capacity in South Korea.
Despite deep losses and cash burn, analyst consensus remains bullish with a $9.60 price target, citing potential in defense and smartphone battery markets. Risks include high cash burn, leadership changes, and competitive pressures. The stock's outlook hinges on successful commercialization and margin improvement.
Genworth Financial (GNW) trades at $8.89, down 1.77% today, with neutral technical signals and mixed fundamental performance. The company maintains stable revenue around $7.1-7.2B but faces margin pressure, with net income declining from $223M to $212M year-over-year. Recent Q2 2026 earnings beat expectations at $0.29 EPS, while the company expanded its share repurchase program by $500M in September 2026.
GNW presents value characteristics with low P/B (0.38) and P/S (0.49) ratios, but weak profitability metrics (ROE 2.42%) and analyst caution (70.59% hold rating) suggest limited near-term catalysts. Key risks include legacy insurance liabilities and competitive pressures, while the upcoming Q3 earnings on November 4 could provide directional clarity.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Enovix designs and manufactures advanced silicon-anode lithium-ion batteries. Its technology aims to provide high energy density and improved performance for mobile devices and consumer electronics.
Read more on ENVX →Genworth Financial, Inc. is a holding company that provides products and services related to aging and long-term care planning, and is the parent company of publicly traded mortgage insurer Enact Holdings, Inc.
Read more on GNW →